Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
2.710
-0.040 (-1.45%)
Jun 25, 2026, 4:00 PM EDT - Market closed
Psyence Biomedical Employees
Psyence Biomedical had 12 employees as of March 31, 2026. The number of employees did not change compared to the previous year.
Employees
12
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$578,035
Market Cap
10.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 12 | 0 | - |
| Mar 31, 2025 | 12 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| Imunon | 20 |
| NuCana | 12 |
| Ernexa Therapeutics | 7 |
| Can-Fite BioPharma | 5 |
| Creative Medical Technology Holdings | 4 |
| CDT Equity | 4 |
| Acurx Pharmaceuticals | 4 |
PBM News
- 9 days ago - Tredium Solutions Selected to Support Scripius' Pharmacy Benefits Platform - Business Wire
- 5 weeks ago - Psyence Biomedical announces U.S. engagement initiative focused on ibogaine - TheFly
- 5 weeks ago - Psyence BioMed Announces U.S. Strategic Engagement Initiative Focused on GMP Ibogaine Research and Manufacturing - GlobeNewsWire
- 2 months ago - Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder - GlobeNewsWire
- 2 months ago - Psyence Biomedical provides update on position in global ibogaine market - TheFly
- 2 months ago - Psyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source - GlobeNewsWire
- 2 months ago - Why Is Psyence Biomedical Stock (PBM) Up Today? - TipRanks
- 2 months ago - Psyence Biomedical Ltd trading resumes - TheFly